Business Wire

VERRENCY

Share
Verrency Appoints Dickson Chu to Global Advisory Board

Global payment innovation company Verrency today announced the appointment of Dickson Chu, an accomplished payments executive and business builder, to its global advisory board.

Mr. Chu has held leadership roles at prominent companies including Paypal, Wells Fargo, Yahoo!, Living Social and Citi, and is a board director and active advisor to a number of emerging payment companies. He is currently the head of BBVA’s San Francisco office for New Digital Businesses, where he has overall BBVA group responsibility for the governance, budget and strategic direction of BBVA’s growing global portfolio of Fintech businesses.

“Verrency is a truly unique company that has significant global momentum,” said Mr. Chu. “Their innovative enabling platform can be deployed on top of existing payment infrastructure, offering a flexible, low-cost, and time efficient way for banks and financial institutions to improve their relationships with customers. They solve a global industry problem, and I’m excited to be joining Verrency where I can help David capitalise on the urgency amongst banks, processors and even super-apps to better compete for their customers around the moment of payment.”

“Dickson’s incredible fintech & payments experience, especially with financial institutions such as BBVA, PayPal and Citi are a tremendous asset as we look to expand the delivery of our patented API platform,” said David Link, Verrency Founder and CEO. “Dickson’s vision, passion and his depth of experience in precisely the area in which Verrency operates are invaluable as we continue our expansion across the United States and overseas. Dickson’s unique insights will also be instrumental as Verrency continues to expand its service offerings into data analytics and other services around the moment of payment.”

Verrency’s industrial-grade platform fits on top of a bank’s, processor’s or wallet’s existing infrastructure, opening the door for rapid delivery of enhanced features and new services without the need to change existing legacy technology or to migrate portfolios. The company has announced agreements with a number of major financial institutions around the world, including UAE-based Emirates NBD, Colombia’s Banco Davivienda, Australia's Volt Bank, and the US-based global processor FIS, among others.

Prior to BBVA, Mr. Chu was Chief Product Officer and EVP Corporate Development at Ingo Money where he was responsible for strategy, product management, strategic alliances and M&A. Ingo Money focuses on transforming consumer access to money by increasing consumer adoption of new and existing digital payment platforms.

Mr. Chu also currently serves on the boards of Simple, Azlo, Covault, Denizen, Upturn, Ingo Money, Boomtown and Opportunity Fund.

About Verrency

Verrency puts financial institutions back at the centre of innovation. Verrency's payments innovation platform helps issuers to acquire and retain customers and increase payment spend while increasing security, control and connectability. Verrency works behind the scenes to enable an ever-increasing range of value-added services for an issuer's customers quickly and easily without major changes to existing payments infrastructure or the need to integrate to point-of-sale systems. Verrency also enables rapid connection to third-party services via its extensive FinTech ecosystem with little to no integration. For more information, see www.verrency.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 Data for Incyte’s Retifanlimab (Zynyz®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet13.6.2025 00:45:00 CEST | Press release

POD1UM-303/InterAACT 2 is the first and largest global Phase 3 trial evaluating a PD-1 inhibitor in combination with chemotherapy for the treatment of patients with advanced SCAC not previously treated with systemic chemotherapy The trial met its primary endpoint; treatment with retifanlimab in combination with platinum-based chemotherapy (carboplatin-paclitaxel) resulted in clinically meaningful improvements in progression-free survival and overall survival In May 2025, the U.S. Food and Drug Administration (FDA) approved Zynyz® (retifanlimab-dlwr) in combination with carboplatin and paclitaxel and as a single agent for the treatment of advanced SCAC; submissions to other global regulatory agencies are also under review Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-base

Güntner Drives Group-Wide Innovation in 2024 Sustainability Report12.6.2025 21:30:00 CEST | Press release

Progress in natural refrigerants, water efficiency and circular economy underscores Güntner’s global impact Güntner, a global leader in refrigeration and heat exchange technology, today announced its featured role in the newly released 2024 A-HEAT Sustainability Report. The report outlines significant progress toward ambitious environmental goals—fueled by Güntner’s commitment to measurable, innovation-led sustainability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612897493/en/ Güntner advances global sustainability goals with progress in natural refrigerants, water savings, and circular economy efforts. Working toward its 2030 sustainability targets, Güntner delivered significant achievements across key areas including natural refrigeration integration, water and energy efficiency and the development of circular economy solutions. These efforts reflect Güntner’s ongoing mission to make sustainability not just a goal,

Windsurf Launches First GPU Cluster in Germany, Expanding Secure Enterprise AI in Europe12.6.2025 20:45:00 CEST | Press release

Windsurf launches a GPU cluster in Germany, delivering 50% faster performance and secure access to European enterprises. Data residency ensures enterprise repositories stay within the EU, meeting stringent security requirements. Windsurf already supports 100+ European enterprise customers, highlighting strong demand for AI-powered development tools across EMEA. Windsurf, a leader in AI-powered software development, today announced its first GPU cluster in Germany, as product demand surges and the company expands performance capacity across the EU. With over 100 local enterprise customers already using Windsurf products, the new cluster marks the company’s first major international step in building scalable infrastructure for the European market. Located in Frankfurt, home to some of the world’s strictest data security laws, the cluster was a natural choice for Windsurf’s first deployment. This cluster was specifically designed to meet the unique security and performance requirements of

Xsolla Partners With Defold to Enable Seamless In-game Purchases for Web Developers12.6.2025 19:00:00 CEST | Press release

New SDK Integration Simplifies Monetization for Defold Developers Publishing on CrazyGames Ahead of Global Game Jam Xsolla, a leading global video game commerce company, announces a new strategic partnership with Defold, the cross-platform game engine trusted by professionals and indie developers worldwide. This collaboration introduces a seamless integration between Xsolla and Defold-built web games on CrazyGames, enabling developers to easily monetize their titles just in time for the CrazyGames x Defold Game Jam running June 13–15. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612569206/en/ (Graphic: Xsolla) To address the complexity of in-game monetization, Xsolla and Defold have developed a new SDK that allows Defold developers to implement in-game purchasing functionality without the complex manual API setup required. With Xsolla’s sponsorship and support, this integration removes friction from the monetization jou

Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies12.6.2025 17:00:00 CEST | Press release

The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyze an ambitious future phase to develop a cancer plasticity atlas encompassing hundreds of millions of cells. Utilizing novel organoid perturbation and Artificial Intelligence (AI) platforms, the aim is to create a comprehensive dataset to fuel foundational drug discovery models and cancer research. Dr. Mathew Garnett, Group Leader at the Sanger Institute, and Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Associate Faculty at the Sanger Institute, will be the principal investigators in the collaboration. Garnett’s research team has generated novel 3D organoid cultures that serve as highly scalable and functional cancer models with the ability to capt

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye